Allergan to advance Botox trial to third phase for treatment of depression

This article was originally published here

Allergan announced to advance its wrinkle treatment Botox to third phase after its phase II study showed a partial benefit in treating patients with major depressive disorder (MDD).

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply